RAHWAY, N.J.--(BUSINESS WIRE) August 8, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...
Vous n'êtes pas connecté
Basel, 04 July 2024 - Roche announced today that the phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial (first-line) treatment for people with...
RAHWAY, N.J.--(BUSINESS WIRE) August 8, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...
This approval is based on late-stage study data, which shows that treatment with AstraZeneca's (AZN) Imfinzi reduced the risk of recurrence by 32% in...
16 August 2024 -- AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
The approval is based on late-stage study data wherein treatment with J&J's (JNJ) Rybrevant plus Lazcluze cut the risk of disease progression or...
Susan Wojcicki, a key figure in the tech industry, passed away at 56 after battling non small cell lung cancer. Known for her roles in founding Google...
The FDA bestows a Breakthrough Therapy Designation to GSK's B7-H3-targeted antibody-drug conjugate, GSK5764227, for relapsed/refractory...
TUESDAY, Aug. 13, 2024 -- Many nonsmokers have lung nodules that have been linked to lung cancer, a new study warns.About 42% of nonsmokers or former...
Lyell Immunopharma, Inc, a clinical─stage T─cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid...
Susan Wojcicki, former YouTube CEO and prominent tech leader, died at 56 after two years of living with non-small cell lung cancer. "It is with...
Business executive Susan Wojcicki, who served as YouTube’s chief executive officer for nine years, died Friday aged 56, her family have announced....